Alina Nicoleta Gavrila-Filip, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyrotoxicosis | 1 | 2016 | 82 | 0.560 |
Why?
|
| Leptin | 6 | 2007 | 1599 | 0.480 |
Why?
|
| Adipose Tissue, Brown | 2 | 2016 | 757 | 0.450 |
Why?
|
| Thermogenesis | 2 | 2016 | 435 | 0.450 |
Why?
|
| Hypothyroidism | 1 | 2016 | 658 | 0.400 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2004 | 1676 | 0.380 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 2 | 2003 | 138 | 0.260 |
Why?
|
| Proteins | 4 | 2004 | 6103 | 0.250 |
Why?
|
| Food Deprivation | 1 | 2004 | 116 | 0.250 |
Why?
|
| Fenofibrate | 1 | 2005 | 88 | 0.250 |
Why?
|
| alpha-MSH | 1 | 2004 | 68 | 0.250 |
Why?
|
| Hypothalamic Hormones | 1 | 2004 | 147 | 0.230 |
Why?
|
| Pituitary Hormones | 1 | 2004 | 183 | 0.230 |
Why?
|
| Activity Cycles | 1 | 2003 | 51 | 0.230 |
Why?
|
| Melanins | 1 | 2004 | 289 | 0.220 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2005 | 1873 | 0.200 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 476 | 0.200 |
Why?
|
| Fasting | 2 | 2004 | 1593 | 0.200 |
Why?
|
| Body Composition | 3 | 2005 | 2401 | 0.170 |
Why?
|
| Vitamin E | 1 | 2003 | 869 | 0.160 |
Why?
|
| Hydrocortisone | 1 | 2003 | 1826 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2016 | 390 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2866 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2624 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 783 | 0.100 |
Why?
|
| Thyroidectomy | 1 | 2016 | 879 | 0.100 |
Why?
|
| Adiponectin | 4 | 2004 | 1100 | 0.090 |
Why?
|
| Insulin Resistance | 4 | 2005 | 3864 | 0.090 |
Why?
|
| Adipose Tissue | 4 | 2013 | 3279 | 0.090 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 2016 | 0.080 |
Why?
|
| Exercise | 1 | 2003 | 5615 | 0.070 |
Why?
|
| Reference Values | 2 | 2004 | 4982 | 0.070 |
Why?
|
| Eating | 2 | 2003 | 1536 | 0.070 |
Why?
|
| Hormones, Ectopic | 1 | 2005 | 40 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2016 | 2899 | 0.060 |
Why?
|
| Agouti-Related Protein | 1 | 2004 | 98 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2016 | 8324 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2282 | 0.060 |
Why?
|
| Cross-Sectional Studies | 6 | 2005 | 25043 | 0.050 |
Why?
|
| Body Size | 1 | 2004 | 461 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 818 | 0.050 |
Why?
|
| Receptors, Leptin | 1 | 2003 | 360 | 0.050 |
Why?
|
| Solubility | 1 | 2003 | 1085 | 0.050 |
Why?
|
| Obesity | 1 | 2003 | 12745 | 0.050 |
Why?
|
| HIV Infections | 3 | 2005 | 16718 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 604 | 0.050 |
Why?
|
| Body Mass Index | 4 | 2007 | 12720 | 0.040 |
Why?
|
| Hypertriglyceridemia | 1 | 2003 | 293 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 789 | 0.040 |
Why?
|
| Adult | 10 | 2016 | 214055 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9438 | 0.040 |
Why?
|
| Diet | 2 | 2004 | 7939 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1663 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6622 | 0.030 |
Why?
|
| Postmenopause | 1 | 2003 | 2461 | 0.030 |
Why?
|
| Middle Aged | 7 | 2016 | 213383 | 0.030 |
Why?
|
| Male | 8 | 2016 | 350118 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 2872 | 0.030 |
Why?
|
| Humans | 12 | 2016 | 744343 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2005 | 12026 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2003 | 3297 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 56430 | 0.020 |
Why?
|
| Female | 8 | 2016 | 380194 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4256 | 0.020 |
Why?
|
| Ion Channels | 1 | 2013 | 1056 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2003 | 8554 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15076 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 996 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Adipocytes | 1 | 2013 | 1184 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 246 | 0.020 |
Why?
|
| HIV-1 | 1 | 2003 | 6939 | 0.020 |
Why?
|
| Resistin | 1 | 2005 | 170 | 0.020 |
Why?
|
| Jaundice, Neonatal | 1 | 2004 | 71 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2004 | 25625 | 0.020 |
Why?
|
| Somatomedins | 1 | 2004 | 192 | 0.020 |
Why?
|
| Greece | 1 | 2004 | 344 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2013 | 2504 | 0.010 |
Why?
|
| Maternal Age | 1 | 2004 | 802 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15165 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2003 | 569 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1583 | 0.010 |
Why?
|
| Body Height | 1 | 2004 | 1577 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1403 | 0.010 |
Why?
|
| Abdomen | 1 | 2003 | 1118 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 85781 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 3493 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11483 | 0.010 |
Why?
|
| Life Style | 1 | 2007 | 3835 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 21827 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 12072 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2585 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10252 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 6459 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12245 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 81183 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2007 | 40561 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 11725 | 0.000 |
Why?
|
| Pregnancy | 1 | 2004 | 29144 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 53288 | 0.000 |
Why?
|
| Animals | 1 | 2013 | 168757 | 0.000 |
Why?
|
| Risk Factors | 1 | 2007 | 72290 | 0.000 |
Why?
|
| Aged | 1 | 2007 | 163280 | 0.000 |
Why?
|